Literature DB >> 6275129

Suppression of vesicular stomatitis virus defective intefering particle generation by a function(s) associated with human chromosome 16.

C Y Kang, L G Weide, J A Tischfield.   

Abstract

Human-mouse somatic cell hybrids were made between adenine phosphoribosyltransferase-deficient mouse L cells and a strain of human primary fibroblasts and selected in medium containing alanosine and adenine (J. A. Tischfield and F. H. Ruddle, Proc. Natl. Acad. Sci. U.S.A. 71:45-49, 1974). These hybrids were tested for the generation of defective interfering (DI) particles of vesicular stomatitis virus to determine whether or not a host gene controls the induction of DI particles. None of the seven independently arising hybrid clones tested generated detectable DI particles during 13 successive undiluted passages. In addition, the parental human cells also failed to generate DI particles. In contrast, the parental mouse cells generated a detectable level of DI particles during continuous passage. Thus, failure to generate DI particles appears to act in a dominant fashion in these hybrids. Human chromosome 16 and adenine phosphoribosyltransferase were present, as a direct consequence of the selection system, in all of the hybrid clones that failed to generate DI particles. It was the only human chromosome observed in the cells of every hybrid clone. This was verified by both isozyme and karyotype analyses. After hybrids were back-selected (with 2,6-diaminopurine) for loss of human adenine phosphoribosyltransferase and chromosome 16, they gained the ability to generate DI particles. Replication of DI particles already present in virus stocks, however, was normal in all of the hybrid clones and the parental human cells. This suggests that the induction, but not the replication, of DI particles is affected by the human genome and that a factor on human chromosome 16 seems to selectively suppress the mouse cell's ability to generate DI particles in the hybrids. These results support the idea that the induction of DI particles is controlled in part by host cell function(s), as suggested previously (C. Y. Kang and R. Allen, J. Virol. 25:202-206, 1978).

Entities:  

Mesh:

Year:  1981        PMID: 6275129      PMCID: PMC256708     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Study of the mechanism of innate resistance to virus infection.

Authors:  G T GOODMAN; H KOPROWSKI
Journal:  J Cell Comp Physiol       Date:  1962-06

2.  Host function-dependent induction of defective interfering particles of vesicular stomatitis virus.

Authors:  C Y Kang; R Allen
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

3.  Inverted complementary terminal sequences in single-stranded RNAs and snap-back RNAs from vesicular stomatitis defective interfering particles.

Authors:  J Perrault; R W Leavitt
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

Review 4.  Viral pathogenesis and molecular biology.

Authors:  A S Huang
Journal:  Bacteriol Rev       Date:  1977-12

5.  Studies on the generation of vesicular stomatitis virus (indiana serotype) defective interfering particles.

Authors:  C Y Kang; T Glimp; J P Clewley; D H Bishop
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

6.  Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus.

Authors:  R M Welsh; P W Lampert; M B Oldstone
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

7.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

8.  The RNAs of infective and incomplete influenza virions grown in MDBK and HeLa cells.

Authors:  P W Choppin; M W Pons
Journal:  Virology       Date:  1970-11       Impact factor: 3.616

9.  Why genes in pieces?

Authors:  W Gilbert
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

10.  Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity.

Authors:  P W Choppin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

View more
  8 in total

Review 1.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

2.  The gene for the human immune interferon receptor is located on chromosome 6.

Authors:  A Rashidbaigi; J A Langer; V Jung; C Jones; H G Morse; J A Tischfield; J J Trill; H F Kung; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 3.  The genetics of vesiculoviruses.

Authors:  C R Pringle
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Genetic instability at the adenine phosphoribosyltransferase locus in mouse L cells.

Authors:  J A Tischfield; J J Trill; Y I Lee; K Coy; M W Taylor
Journal:  Mol Cell Biol       Date:  1982-03       Impact factor: 4.272

5.  Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma.

Authors:  V Jung; A Rashidbaigi; C Jones; J A Tischfield; T B Shows; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 6.  Defective Interfering Particles of Negative-Strand RNA Viruses.

Authors:  Christopher M Ziegler; Jason W Botten
Journal:  Trends Microbiol       Date:  2020-03-26       Impact factor: 17.079

7.  A specific sequence in the genome of respiratory syncytial virus regulates the generation of copy-back defective viral genomes.

Authors:  Yan Sun; Eun Ji Kim; Sébastien A Felt; Louis J Taylor; Divyansh Agarwal; Gregory R Grant; Carolina B López
Journal:  PLoS Pathog       Date:  2019-04-17       Impact factor: 6.823

Review 8.  Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo.

Authors:  L Roux; A E Simon; J J Holland
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.